Search for: "Case v. Hatch" Results 21 - 40 of 932
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2013, 4:45 am by Eric Guttag
I don’t know if you would call me an expert, but I’ve studied many, many cases involving Paragraph IV Certifications under Hatch-Waxman. [read post]
2 Apr 2007, 9:52 pm
For the latest version of the Hatch-Waxman Tracker, click here. [read post]
7 Aug 2012, 7:27 am by Gene Quinn
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
7 Aug 2012, 7:27 am by Gene Quinn
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
7 Aug 2012, 7:27 am by Eric Guttag
While the Supreme Court may have expanded the reach of the Hatch-Waxman “safe harbor,” the Medtronic and Merck cases only involved pre-marketing FDA approval activity. [read post]
18 Apr 2024, 7:49 am by Dan Farber
The worst-case scenario is easy to envision based on opinions to date. [read post]
18 Apr 2012, 9:12 pm by Patent Docs
By Andrew Williams -- In a second case involving the Hatch-Waxman regulatory scheme decided by the Federal Circuit on Monday, the Court held in Bayer Schering Pharma AG v. [read post]
9 Nov 2021, 9:31 pm by Patent Docs
The case arose over Celgene's multiple-myeloma drug pomalidomide (Pomalyst). [read post]
3 Apr 2024, 8:18 pm by Patent Docs
§ 271(e)(1) was the occasion for the Federal Circuit to illustrate the continued debate over the scope of the safe harbor enacted as part of the Hatch-Waxman Act in Edwards Lifesciences Corp. v. [read post]